Ticker League

AstraZeneca (AZN) Free Cash Flow Bridge

Pinpoint what moved AstraZeneca's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

-5.88%

OCF YoY

+9.33%

Capex YoY

+52.51%

FCF Conversion Δ

-10.3 pp

Free cash flow bridge for AstraZeneca (AZN) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: −$569.49M

FCF bridge breakdown for AstraZeneca (AZN) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$9.68B
  • Operating Cash Flow$1.22B
  • Capital Expenditure−$1.79B
  • Free Cash Flow$9.11B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology